Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new ...
Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...
Adherence support is effective but requires effort and investment Digital adherence technologies have emerged as promising ...
Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...
Europe accounts for a comparatively low share of the global tuberculosis burden, yet the proportion of newly diagnosed cases with multidrug-resistant (MDR) or rifampicin-resistant (RR; a surrogate for ...
Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results